Chemed To Report Fourth-Quarter 2022 Earnings February 23, Related Conference Call To Be Held On February 24
Chemed Corporation (NYSE: CHE) has announced that it will release its financial results for the fourth quarter ended December 31, 2022, on February 23, 2023, post-market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Chemed will host a conference call and webcast at
Participants may access a live webcast of the conference call through the investor relations section of Chemed’s website, Investor Relations Home |
Participants may also register via teleconference at: https://register.vevent.com/register/BIa68c5dbaf8b34e36b34d624d6cd5cc4a. Once registration is completed, participants will be provided with a dial-in number containing a personalized conference code to access the call. All participants are instructed to dial-in 15 minutes prior to the start time.
A taped replay of the conference call will be available beginning approximately two hours after the call's conclusion. You may access the replay via webcast through the investors relations section of Chemed’s website.
Listed on the
Statements in this press release or in other Chemed communications may relate to future events or Chemed's future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk and that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230209005001/en/
(513) 762-6901
Source: